American International Group’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-35,249
Closed -$632K 3659
2016
Q1
$632K Buy
35,249
+3,806
+12% +$69.1K ﹤0.01% 1825
2015
Q4
$743K Sell
31,443
-3,968
-11% -$98.4K ﹤0.01% 1701
2015
Q3
$797K Sell
35,411
-1,560
-4% -$43.7K ﹤0.01% 1626
2015
Q2
$1.04M Buy
36,971
+1,316
+4% +$36.5K ﹤0.01% 1551
2015
Q1
$983K Buy
35,655
+2,252
+7% +$61.4K ﹤0.01% 1619
2014
Q4
$831K Buy
33,403
+1,273
+4% +$30.5K ﹤0.01% 1721
2014
Q3
$710K Sell
32,130
-901
-3% -$19.6K ﹤0.01% 1832
2014
Q2
$686K Buy
33,031
+23
+0.1% +$483 ﹤0.01% 1903
2014
Q1
$718K Buy
33,008
+12,266
+59% +$273K ﹤0.01% 1816
2013
Q4
$424K Buy
20,742
+12,825
+162% +$249K ﹤0.01% 2149
2013
Q3
$152K Buy
7,917
+2,724
+52% +$52.2K ﹤0.01% 2960
2013
Q2
$92.8K Buy
+5,193
New +$93.8K ﹤0.01% 3200

Other funds holding HQL

American International Group's HQL Position: Q2 2016 in Review

American International Group sold out of abrdn Life Sciences Investors (HQL) in Q2 2016, closing a stake of 35,249 shares — an estimated $632K sold.

American International Group first reported a position in HQL in Q2 2013 and held it in 12 quarters. The position peaked at $1.04M in Q2 2015. 50 funds tracked by Wall St. Rank hold HQL as of Q2 2016.

  • American International Group reported no remaining abrdn Life Sciences Investors position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 35,249 abrdn Life Sciences Investors shares in Q2 2016, an estimated $632K.
  • American International Group first reported a position in abrdn Life Sciences Investors in Q2 2013 and held it in 12 quarters.
  • American International Group's abrdn Life Sciences Investors position peaked at $1.04M in Q2 2015.
  • 50 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.